Bioelectronics Corp Stock Probability of Future Pink Sheet Price Finishing Over 3.0E-4
| BIEL Stock | USD 0.0003 0.0001 50.00% |
Bioelectronics |
Bioelectronics Corp Target Price Odds to finish over 3.0E-4
The tendency of Bioelectronics Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.0003 | 90 days | 0.0003 | about 42.07 |
Based on a normal probability distribution, the odds of Bioelectronics Corp to move above the current price in 90 days from now is about 42.07 (This Bioelectronics Corp probability density function shows the probability of Bioelectronics Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the pink sheet has the beta coefficient of 5.06 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Bioelectronics Corp will likely underperform. Additionally Bioelectronics Corp has an alpha of 0.9229, implying that it can generate a 0.92 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Bioelectronics Corp Price Density |
| Price |
Predictive Modules for Bioelectronics Corp
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bioelectronics Corp. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bioelectronics Corp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bioelectronics Corp Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Bioelectronics Corp is not an exception. The market had few large corrections towards the Bioelectronics Corp's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bioelectronics Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bioelectronics Corp within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.92 | |
β | Beta against Dow Jones | 5.06 | |
σ | Overall volatility | 0.00004 | |
Ir | Information ratio | 0.06 |
Bioelectronics Corp Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bioelectronics Corp for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bioelectronics Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Bioelectronics Corp is way too risky over 90 days horizon | |
| Bioelectronics Corp has some characteristics of a very speculative penny stock | |
| Bioelectronics Corp appears to be risky and price may revert if volatility continues | |
| Bioelectronics Corp has high likelihood to experience some financial distress in the next 2 years | |
| Bioelectronics Corp currently holds 13.34 M in liabilities. Bioelectronics Corp has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Bioelectronics Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Bioelectronics Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bioelectronics Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bioelectronics to invest in growth at high rates of return. When we think about Bioelectronics Corp's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 1.61 M. Net Loss for the year was (289.82 K) with profit before overhead, payroll, taxes, and interest of 795.53 K. | |
| Bioelectronics Corp currently holds about 925 in cash with (320.3 K) of positive cash flow from operations. | |
| Latest headline from 9to5toys.com: Philips affordable Sonicare One rechargeable toothbrush falls to 21 Prime shipped |
Bioelectronics Corp Technical Analysis
Bioelectronics Corp's future price can be derived by breaking down and analyzing its technical indicators over time. Bioelectronics Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Bioelectronics Corp. In general, you should focus on analyzing Bioelectronics Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Bioelectronics Corp Predictive Forecast Models
Bioelectronics Corp's time-series forecasting models is one of many Bioelectronics Corp's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Bioelectronics Corp's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Bioelectronics Corp
Checking the ongoing alerts about Bioelectronics Corp for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Bioelectronics Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Bioelectronics Corp is way too risky over 90 days horizon | |
| Bioelectronics Corp has some characteristics of a very speculative penny stock | |
| Bioelectronics Corp appears to be risky and price may revert if volatility continues | |
| Bioelectronics Corp has high likelihood to experience some financial distress in the next 2 years | |
| Bioelectronics Corp currently holds 13.34 M in liabilities. Bioelectronics Corp has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Bioelectronics Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Bioelectronics Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bioelectronics Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bioelectronics to invest in growth at high rates of return. When we think about Bioelectronics Corp's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 1.61 M. Net Loss for the year was (289.82 K) with profit before overhead, payroll, taxes, and interest of 795.53 K. | |
| Bioelectronics Corp currently holds about 925 in cash with (320.3 K) of positive cash flow from operations. | |
| Latest headline from 9to5toys.com: Philips affordable Sonicare One rechargeable toothbrush falls to 21 Prime shipped |
Other Information on Investing in Bioelectronics Pink Sheet
Bioelectronics Corp financial ratios help investors to determine whether Bioelectronics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioelectronics with respect to the benefits of owning Bioelectronics Corp security.